In the current global market landscape, volatility has been a significant theme, with U.S. stocks experiencing fluctuations due to competitive pressures in the tech sector and ongoing geopolitical ...

Highlights:,Institutional investment managers have adjusted their positions in Veracyte (NASDAQ:VCYT).,The company registered ...

Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

BioSpace Senior Editor Annalee Armstrong headed to the J.P. Morgan Healthcare Conference with a months-long story idea ...

President Donald Trump's tariff dispute with China, Canada and Mexico over fentanyl smuggling and illegal immigration has led ...

More about Alterity Therapeutics Ltd. Alterity Therapeutics Ltd. operates in the biotechnology industry, focusing on the development of therapies for neurodegenerative diseases. Y ...

"Congratulations to Nancy Etnier, who has been promoted to executive vice president, chief human resources officer," the ...

With 10K genomic data now publicly available, India takes a major leap in genetic research. In today’s 'Knowledge Nugget', ...

In today's rapidly changing business environment, leadership and values are crucial to achieving growth. The stories of visionary leaders have long inspired and shaped industries. In this second ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

On Wednesday the U.S. Department of Commerce announced it would implement new export controls on certain biotechnology equipment, citing national security concerns relating to artificial ...